Two new atypical antipsychotics: advantages and disadvantages.
作者信息
Lemon M D
出版信息
S D J Med. 1998 Aug;51(8):285-6.
PMID:9724957
Abstract
摘要
相似文献
1
Two new atypical antipsychotics: advantages and disadvantages.
S D J Med. 1998 Aug;51(8):285-6.
2
The value of atypical antipsychotics in the treatment of schizophrenia.
Manag Care. 2002 Jul;11(7 Suppl):8-12; discussion 12-3.
3
The new antipsychotic compounds: is a clinical choice algorithm possible?
West J Med. 1998 Jul;169(1):43-4.
4
Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.
J Clin Psychiatry. 2003 Sep;64(9):1133-4. doi: 10.4088/jcp.v64n0921f.
5
Massive increase in serum creatine kinase during olanzapine and quetiapine treatment, not during treatment with clozapine.
Psychopharmacology (Berl). 2000 Jun;150(3):347-8. doi: 10.1007/s002130000464.
6
Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
J Clin Psychiatry. 2003 May;64(5):598-604. doi: 10.4088/jcp.v64n0516.
7
Measuring outcome in schizophrenia: differences among the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry. 1998;59 Suppl 12:3-9.
8
Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
Am J Psychiatry. 2002 Apr;159(4):561-6. doi: 10.1176/appi.ajp.159.4.561.
9
Antipsychotic drug side effect issues in bipolar manic patients.
J Clin Psychiatry. 2000;61 Suppl 8:52-61; discussion 62-3.
10
Schizophrenia, VI: Treatments.
Am J Psychiatry. 2003 Oct;160(10):1748. doi: 10.1176/appi.ajp.160.10.1748.
Zotero 插件